AUDIT COMMITTEE

The chairman of the Audit Committee is Brian N. Edang, Independent Director of Medilines Distributors Incorporated. Mr. Edang, 43, is a Certified Public Accountant. He graduated cum laude with a Bachelor of Science in Accountancy from the University of St. La Salle in Bacolod. He is currently the Chief Financial Officer & Head Investor Relations of Vista Land & Lifescapes, Inc. He is also Treasurer and Director of the following companies: Vista Residences Incorporated, Brittany Corporation, Crown Asia Properties, Crown Asia Properties Incorporated, Communities Philippines Incorporated, and Camella Homes Incorporated. Prior to joining the group, he was with SGV & Co. (EY Philippines) as an external auditor from 1999 to 2004. He is the Chief Financial Officer of Vista Land since November 2018. Mr. Edang is a member of the Philippine Institute of Certified Public Accountants (PICPA) and the Financial Executives Institute of the Philippines (FINEX). The members of the committee include Chairman of the Board, Virgilio B. Villar; and Independent Director, Fernando Sixto V. Segovia. The Audit Committee will also implement policies on Related Party Transactions and Board Risk Oversight.

CORPORATE GOVERNANCE COMMITTEE

The chairman of the Corporate Governance Committee is Fernando Sixto V. Segovia, Independent Director of Medilines Distributors Incorporated. Mr. Segovia, 61, is a Managing Director at ADP Pharma Corporation. He has held several directorship and head executive positions in various healthcare companies, including Pascual Total Health, Exeltis Pharma, Novartis Healthcare, InterMed Marketing Philippines, Bristol Myers Squibb, Pfizer Philippines, Ciba-Geigy, and Warner-Lambert. He was the President and majority owner of Seville Pharmaceuticals Incorporated. He is a candidate for Master of Business Administration Senior Executive Program in Ateneo de Manila. He graduated from San Beda College with a degree in Bachelor of Science in Management. The members of the committee include Director and President, Patricia V. Yambing; and Independent Director, Brian N. Edang. The Corporate Governance Committee will also implement policies on Nominations and Renumeration.